80
8
Growth Score
-9 pts
Heat Score
-21 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
399470
Dr Ashleys is a pharmaceutical company that develops specialized and complex APIs and orphan drugs for rare diseases.
About the Company
Drug Manufacturer – Specialty & Generic Dr. Ashleys Limited is a global pharmaceutical company, together with its subsidiaries, specializing in the development, manufacturing, and marketing of Active Pharmaceutical Ingredients (API) and Orphan Drugs. The company also offers Contract Research and Manufacturing Services (CRAMS). Founded in 2012,
the company's mission is to deliver life-saving drugs to underserved markets while maintaining profitability. The company is committed to producing affordable APIs and Orphan Drugs for rare diseases, targeting the epicenter of various health challenges. The company distributes over 85 products to over 80 countries in six major therapeutic segments.
